107 related articles for article (PubMed ID: 6210393)
1. Systemic compliance, renal hemodynamics, and sodium excretion in hypertension.
London GM; Levenson JA; London AM; Simon AC; Safar ME
Kidney Int; 1984 Sep; 26(3):342-50. PubMed ID: 6210393
[TBL] [Abstract][Full Text] [Related]
2. Plasma prostaglandins PGE2 and PGF2 alpha, total effective vascular compliance and renal plasma flow in essential hypertension.
London GM; Hornych A; Safar ME; Levenson JA; Simon AC
Nephron; 1982; 32(2):118-24. PubMed ID: 6960267
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
4. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
5. Renal sodium excretion and the peritubular capillary physical factors in essential hypertension.
Willassen Y; Ofstad J
Hypertension; 1980; 2(6):771-9. PubMed ID: 7461793
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal pressure and sodium excretion in hypertension of chronic glomerulonephritis in humans.
Willassen Y; Ofstad J
Hypertension; 1983; 5(3):375-84. PubMed ID: 6840824
[TBL] [Abstract][Full Text] [Related]
7. Renal filtration fraction, effective vascular compliance, and partition of fluid volumes in sustained essential hypertension.
London GM; Safar ME; Levenson JA; Simon AC; Temmar MA
Kidney Int; 1981 Jul; 20(1):97-103. PubMed ID: 7300119
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of atrial natriuretic peptide during dopamine infusion.
Hirata Y; Fukui K; Hayakawa H; Suzuki E; Sugimoto T; Kimura K; Matsuoka H; Sugimoto T
Am J Hypertens; 1990 Nov; 3(11):866-9. PubMed ID: 2175625
[TBL] [Abstract][Full Text] [Related]
10. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
Herlitz H; Jungersten LU; Wikstrand J; Widgren BR
Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
[TBL] [Abstract][Full Text] [Related]
11. Extracellular fluid volume and renal indices in essential hypertension.
Simon AC; Safar ME; Levenson JA; Aboras NE; Alexandre JM; Pauleau NF
Clin Exp Hypertens (1978); 1979; 1(5):557-76. PubMed ID: 533674
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery.
London GM; Safar ME
Am J Hypertens; 1989 Apr; 2(4):244-52. PubMed ID: 2706091
[TBL] [Abstract][Full Text] [Related]
13. Intrarenal hemodynamics in patients with essential hypertension.
Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H; Kawamura M
Circ Res; 1991 Aug; 69(2):421-8. PubMed ID: 1860182
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.
Predel HG; Schulte-Vels O; Glänzer K; Meyer-Lehnert H; Kramer HJ
Am J Hypertens; 1991 Nov; 4(11):871-9. PubMed ID: 1665067
[TBL] [Abstract][Full Text] [Related]
15. Family history and pathophysiological mechanisms of primary hypertension. Studies in non-hypertensive young men with positive and negative family histories of hypertension.
Widgren BR
Scand J Urol Nephrol Suppl; 1991; 134():1-75. PubMed ID: 1887213
[TBL] [Abstract][Full Text] [Related]
16. The effect of dietary sodium loading on the kinetics of sodium excretion and blood pressure regulation in essential hypertensive men.
Manitius J; Kliz J; Krupa-Wojciechowska B
Cor Vasa; 1985; 27(1):29-35. PubMed ID: 3888529
[TBL] [Abstract][Full Text] [Related]
17. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
[TBL] [Abstract][Full Text] [Related]
18. Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
Ruilope LM; Miranda B; Garcia-Robles R; Bigorra J; Oliet A; Alcazar JM; Sancho Rof J; Rodicio JL
J Cardiovasc Pharmacol; 1989 Jan; 13(1):90-3. PubMed ID: 2468941
[TBL] [Abstract][Full Text] [Related]
19. Role of renal hemodynamics in the exaggerated natriuresis of essential hypertension.
Coruzzi P; Musiari L; Biggi A; Ravanetti C; Vallisa D; Montanari A; Novarini A
Kidney Int; 1988 Apr; 33(4):875-80. PubMed ID: 3386140
[TBL] [Abstract][Full Text] [Related]
20. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
